New Cancer Treatment

There has been an astounding breakthrough in the medical community.  ImMucin, a vaccine that targets a molecule present in 90 percent of all cancers, has been successfully tested on humans for the first time, with all the blood cancer patients tested in the trial had greater immunity to the disease after receiving the drug.  The vaccine works by priming the body’s natural defense mechanisms to fight the disease, and aims to prevent cancer conditions, rather than attack cancer cells like many other treatments.  While the immune system generally attacks foreign cells like bacteria and viruses, it often fails to recognize cancer cells because tumors are formed from patients’ defective cells.  ImMucin teaches the immune system to recognize and attack cancer cells.  While this treatment does not cure cancer in all cases, it is a breakthrough mainly because of how it attacks cancer (or rather, how it doesn't).  By marking cancer cells, there aren't the negative effects and tissue damage done by chemotherapy or radiation.  Instead, its relatively harmless.  Hopefully this treatment will be commercially available soon so that the world can benefit from it